glp 1 agonist dpp 4 inhibitor DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits Frontiers | Clinical Use of
Description
Morgan Stanley analysts noted in 2025 that GLP-1 adoption is reshaping consumer behavior at a population level how people eat, shop, exercise, and perceive themselves
GLP-1 Receptor Agonists and Inflammatory Pathway Modulation: Dual Targeting of Metabolic and Immune Dysfunction in Insulin Resistance
N., Wharton, S., Connery, L., Alves, B., et al
H., Dee P
It acts by mimicking the effects of GLP-1, a hormone produced in the intestines that regulates blood sugar levels, promotes weight loss, and enhances overall metabolic function
10.1111/dom.12595 [DOI] [PubMed] [Google Scholar] 50.Almagthali AG, Alkhaldi EH, Alzahrani AS, Alghamdi AK, Alghamdi WY, Kabel AM
